CARDIOPROTECTIVE EFFECT OF l‐GLUTAMATE IN OBESE TYPE 2 DIABETIC ZUCKER FATTY RATS
- 30 August 2009
- journal article
- research article
- Published by Wiley in Clinical and Experimental Pharmacology and Physiology
- Vol. 36 (9) , 892-898
Abstract
SUMMARY: Because diabetic hearts have an increased threshold for cardioprotection by ischaemic preconditioning (IPC), we hypothesized that protection by l‐glutamate during reperfusion is restricted in Type 2 diabetic hearts. Previously, we found that l‐glutamate‐mediated postischaemic cardioprotection mimics IPC. Rat hearts were studied in a Langendorff preparation perfused with Krebs’–Henseleit solution and subjected to 40 min global no‐flow ischaemia, followed by 120 min reperfusion. l‐Glutamate (0, 15 and 30 mmol/L) was added to the perfusate during reperfusion of hearts from non‐diabetic (Wistar‐Kyoto) and diabetic (Zucker diabetic fatty (ZDF)) rats, studied at 16 weeks of age. The infarct size (IS)/area‐at‐risk (AAR) ratio was the primary end‐point. Expression of l‐glutamate excitatory amino acid transporter (EAAT) 1 (mitochondrial) and EAAT3 (sarcolemmal) was determined by quantitative polymerase chain reaction and immunoblotting. The ISS/AAR ratio did not differ between control hearts from Wistar‐Kyoto and ZDF rats (0.52 ± 0.03 and 0.51 ± 0.04, respectively; P = 0.90). l‐Glutamate (15 mmol/L) significantly reduced the IS/AAR ratio in non‐diabetic hearts, but not in diabetic hearts, compared with their respective controls. The higher concentration of l‐glutamate (30 mmol/L) reduced infarct size in diabetic hearts to the same degree as in non‐diabetic hearts (IS/AAR 0.35 ± 0.03 (P = 0.002) and 0.34 ± 0.03 (P = 0.004), respectively). The mitochondrial l‐glutamate transporter EAAT1 was downregulated in hearts from ZDF rats at both the mRNA and protein levels (P < 0.0005 and P < 0.0001, respectively). However, there was no change in EAAT3 expression at the protein level. Myocardial l‐glutamate content was increased by 43% in diabetic hearts (P < 0.0001). Hearts from obese diabetic rats have an elevated threshold for metabolic postischaemic cardioprotection by l‐glutamate. These findings may reflect underlying mechanisms of inherent resistance against additional cardioprotection in the diabetic heart.Keywords
This publication has 31 references indexed in Scilit:
- CARDIOPROTECTION BY l‐GLUTAMATE DURING POSTISCHAEMIC REPERFUSION: REDUCED INFARCT SIZE AND ENHANCED GLYCOGEN RESYNTHESIS IN A RAT INSULIN‐FREE HEART MODELClinical and Experimental Pharmacology and Physiology, 2008
- Mechanisms Underlying Acute Protection From Cardiac Ischemia-Reperfusion InjuryPhysiological Reviews, 2008
- l‐GLUTAMATE AND GLUTAMINE IMPROVE HAEMODYNAMIC FUNCTION AND RESTORE MYOCARDIAL GLYCOGEN CONTENT DURING POSTISCHAEMIC REPERFUSION: A RADIOACTIVE TRACER STUDY IN THE RAT ISOLATED HEARTClinical and Experimental Pharmacology and Physiology, 2006
- Expression of Glutamate Transporters in Rat Cardiomyocytes and Their Localization in the T-tubular SystemJournal of Histochemistry & Cytochemistry, 2004
- Localization and function of the brain excitatory amino acid transporter type 1Bin cardiac mitochondriaJournal of Molecular and Cellular Cardiology, 2004
- Glutamate loading protects freshly isolated and perfused adult cardiomyocytes against intracellular ROS generationJournal of Molecular and Cellular Cardiology, 2003
- Regulation of Glycolytic Flux in Ischemic PreconditioningJournal of Biological Chemistry, 2002
- MECHANISMS OF MYOCARDIAL PROTECTION BY AMINO ACIDS: FACTS AND HYPOTHESESClinical and Experimental Pharmacology and Physiology, 1996
- Altered global myocardial substrate preference at rest and during pacing in coronary artery disease with stable angina pectorisThe American Journal of Cardiology, 1988
- Effect of glutamic and aspartic acids on adenine nucleotides, nitrogenous compounds and contractile function during underperfusion of isolated rat heartJournal of Molecular and Cellular Cardiology, 1983